AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid Arthritis

AIM: Examine the efficacy of once-weekly subcutaneous tocilizumab (SC-TCZ) on joint damage at 24 weeks based on radiography of the hands and feet and magnetic resonance imaging (MRI) of the hand in subjects with moderate to severe rheumatoid arthritis (RA). METHODS: In this Australian open-label, mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bird, Paul, Peterfy, Charles, Countryman, Peter, Griffiths, Hedley, Barrett, Rina, Youssef, Peter, Joshua, Fredrick, Hall, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925169/
https://www.ncbi.nlm.nih.gov/pubmed/29849651
http://dx.doi.org/10.1155/2018/8721753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925169/
https://www.ncbi.nlm.nih.gov/pubmed/29849651
http://dx.doi.org/10.1155/2018/8721753

Ejemplares similares